Search

Search Constraints

You searched for: Author/Creator Ottosson, W.

Search Results

1. EP-1352 Locally advanced NSCLC: performance status based eligibility for adjuvant check point inhibitor. (April 2019)

5. EP-1932: Quality assurance in implementing a national dose escalation trial in NSCLC – report from NARLAL2. (April 2016)

6. MO-0550 Pre-study QA reduces delineation errors and minimize dose to OAR in a central lung tumour SBRT trial. (May 2022)

7. OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial. (April 2016)

9. PO-0754: Safe inhomogeneus RT dose escalation in locally advanced NSCLC, -interim results from NARLAL2. (April 2018)